Ophthalmologic Center of the Second Hospital, Jilin University, Changchun, People's Republic of China.
Department of Ophthalmology, Linyi Central Hospital, Linyi, Shandong, People's Republic of China.
Ocul Immunol Inflamm. 2024 Nov;32(9):2000-2007. doi: 10.1080/09273948.2024.2315189. Epub 2024 Feb 20.
At present, the severity and grade of anterior scleritis are judged mainly based on the area and location of involvement, whether there is necrosis, etc. Quantitative measurement of sclera and surrounding tissues will help to accurately assess the severity of scleritis and provide quantitative indicators for the choice of treatment.
We retrospectively analyzed the thickness of sclera and ciliary bodies detected by ultrasound biological microscopy (UBM) in noninfectious anterior scleritis patients who subsequently were treated with topical or systemic treatment, and visited our hospital from March 2014 to March 2021. Age- and sex-matched normal individuals were used as controls.
A total of 185 patients (50 males and 135 females) with noninfectious anterior scleritis and 84 (31 males and 53 females) controls were included. In patients with noninfectious scleritis, the thickness of sclera and the ciliary body were significantly greater than those in the control group ( < 0.05). Before treatment, the thickness of sclera and the ciliary body in systemic treatment group was significantly higher than that in topical treatment group ( < 0.05). After treatment, both thicknesses of sclera and the ciliary body decreased significantly ( < 0.05). The ratio of ciliary body thickness from the site of inflammation to the normal position was significantly higher in the systemic treatment group than in the topical treatment group.
UBM quantitatively shows a decrease in AST/CBT in patients with anterior scleritis after treatment. The ratio of ciliary body thickness at the site of information to that at the normal position may be a reference for the choice of treatment.
目前,前巩膜炎的严重程度和分级主要依据受累的范围和部位、是否有坏死等进行判断。巩膜及其周围组织的定量测量有助于准确评估巩膜炎的严重程度,并为治疗方案的选择提供定量指标。
我们回顾性分析了 2014 年 3 月至 2021 年 3 月间因非感染性前巩膜炎接受局部或全身治疗后就诊于我院的超声生物显微镜(UBM)检测的巩膜和睫状体厚度,同时选取年龄和性别相匹配的正常人为对照组。
共纳入 185 例(50 例男性,135 例女性)非感染性前巩膜炎患者和 84 例(31 例男性,53 例女性)对照组。非感染性巩膜炎患者的巩膜和睫状体厚度明显大于对照组(均<0.05)。全身治疗组治疗前巩膜和睫状体厚度明显高于局部治疗组(均<0.05)。治疗后,两组巩膜和睫状体厚度均明显降低(均<0.05)。全身治疗组炎症部位睫状体厚度与正常部位厚度的比值明显高于局部治疗组。
UBM 定量显示前巩膜炎患者治疗后 AST/CBT 降低。睫状体厚度在炎症部位与正常部位的比值可能是治疗选择的参考。